Come up with a name for your new list and we'll add to it:
Surrozen raised a round of funding on February 15, 2017. Investors include
The Column Group.
Surrozen is a biopharmaceutical company focusing on discovering and developing drugs that promote the repair and regeneration of human tissues.…